ArticleBMJ open2024

Clinical predictors of 3-month isoniazid rifapentine (3HP)-related adverse drug reactions (ADR) during tuberculosis preventive therapy (PAnDoRA-3HP study): an observational study protocol.

Christine Sekaggya-Wiltshire et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.